Sélectionnez l'édition
Pays
Objectif principal
Maladie
Type d'Organisation
Partie prenante
Qualité
Second Edition BOGP (0)
Norvège (1)
Gap analysis
Across all conditions/Other (1)
Patient Advocacy Organization (4)
Pharmaceutical companies or industry (incl. Medical device and biotech companies)
Capacity and capabilities for engagement
Clinical study phase I